Abstract:Retinoic acid inducible-gene I (RIG-I) detects short dsRNA and stem-loop RNA species bearing a 5'-triphosphate end, and functions as one of the major sensors of RNA viruses (Myong, Cui et al., 2009, Pichlmair, Schulz et al., 2006). DDX58, which encodes the RIG-I protein has been newly identified as a susceptibility gene in psoriasis, a chronic inflammatory skin disorder affecting the skin in 1-3% of the general population (2009, Tsoi, Spain et al., 2012). Recently, interleukin (IL)-23 has been demonstrated as a key master cytokine that promotes T helper 17 (Th17) cell survival and proliferation, and targeting the IL-23p19 subunit with a monoclonal antibody results in the clinical improvement in psoriasis (Kopp, Riedl et al., 2015, Zheng, Danilenko et al., 2007). Yet what triggers IL-23 production in the skin of individuals genetically predisposed to develop psoriasis is still unclear. Here, we show that RIG-I expression is increased in the affected skin derived from psoriasis patients and from IL-23-induced mouse model of psoriasis. The activation of RIG-I by 5'ppp-dsRNA, its synthetic ligand, directly causes the production of IL-23 and promotes chronic cutaneous inflammation in mice that closely resembles human psoriasis. Repeated injections of IL-23 to the ears failed to induce IL-23 production and a full psoriasiform skin phenotype, both in germ-free and RIG-I knockout mice. Furthermore, RIG-I-mediated IL-23 production was confined to the CD11c+ myeloid dendritic cells (mDCs) via nuclear factor-kappa B (NF-κB) signaling, and stimulated RIG-I expression in an auto-regulatory feedback loop. Thus, our data suggest that the RIG-I-mediated antiviral response is pivotal for the local IL-23 production in the mDCs and for the IL-23-induced psoriasiform skin inflammation in mice, supporting the notion that dysregulation in the antiviral immune responses of hosts through the innate pattern-recognition receptors may trigger the skin inflammatory conditions in the pathophysiology of psoriasis.

IL-23 induces CLEC5A+ IL-17A+ neutrophils and elicit skin inflammation associated with psoriatic arthritis

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

IL-17C Amplifies Epithelial Inflammation in Human Psoriasis and Atopic Eczema

Epigenetic Regulation of IL-23 by E3 Ligase FBXW7 in Dendritic Cells is Critical for Psoriasis-like Inflammation.

Pivotal Role of Dermal IL-17-Producing Γδ T Cells in Skin Inflammation

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation

Synergistic Induction of IL-23 by TNFα, IL-17A, and EGF in Keratinocytes.

592 RIG-I Antiviral Signaling Drives Interleukin-23 Production and Psoriasis-Like Skin Disease

IL23R mutations associated with decreased risk of psoriasis lead to the differential expression of genes implicated in the disease

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints

Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside

CCR7 DC Define a Type 17 Module in Psoriasis

A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response

IL‐23/IL‐17 immune axis mediates the imiquimod‐induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF‐κB pathway in macrophages and keratinocytes

Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis

The immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target

712 Comparing RNAseq Analysis of the Mouse IL-23 Minicircle Model to Human Psoriasis and Other Preclinical Models of Skin Inflammation

Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis

An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.